Emergency Medical Products, Inc. Launches New Website with Enhanced Capabilities and User Experience
DUBLIN, Ohio, Oct. 5, 2020 /PRNewswire/ — Emergency Medical Products (EMP) launched their new-and-improved website on October 4, 2020. The fully-responsive site offers a seamless online shopping experience on virtually any device. Enhanced functionality and features allow users to effortlessly place orders at buyemp.com.
The website offers easy-to-use search and navigation functions to help users shop over 8,000 medical and safety products. Capabilities like faceted search help easily and efficiently filter down to the perfect product, while the product availability feature provides an accurate stock status of the desired item.
There are a number of other notable site proficiencies that deserve recognition. The improved Loyalty Rewards Program allows users to earn points on every product purchased online, and redeem those points for credit on future orders. Multiple supply lists can be created and shared for quick and easy ordering of frequently purchased items. Finally, self-serve reports enable customers to view previous orders, purchase summaries and more.
“We are very excited to announce the launch of our newly designed, mobile-responsive website,” said Andrew Love, Vice President and General Manager, EMP. “As a leading provider of medical supplies and equipment, we wanted to offer a new site that is user-friendly, easy to navigate and provides users the information needed to quickly make informed buying decisions.”
About Sarnova and Emergency Medical Products
Emergency Medical Products (EMP) is part of the Sarnova family of companies—the leading national specialty distributor of healthcare products across four major business units: Bound Tree Medical, Cardio Partners, Emergency Medical Products and Tri-anim Health Services.
Emergency Medical Products (EMP) is dedicated to helping those who save and improve patient lives. For nearly 50 years, EMP has provided medical supplies to healthcare professionals and first responders. EMP continually expands their product offering to better meet the needs of
Clinical trials into a COVID-19 vaccine as well as research into other diseases have been delayed following a ransomware attack on a company that provides software to medical firms.
First reported Saturday by The New York Times, the attack targeted eResearchTechnology Inc., a Philadelphia-based company that specializes in clinical software. The attack is said to have been detected two weeks ago when employees discovered they were locked out of their data by ransomware.
As a result of the ransomware attack, companies using ERT’s software were also affected. Among those were IQVIA Inc., a research organization helping managing AstraZeneca plc’s coronavirus vaccine trial, and Bristol Myers Squibb Co., a drug company leading a consortium of companies developing a quick COVID-19 test.
Clinical trial patients were not affected, but researchers were forced to resort to pen and paper to track patients.
How many companies and health organizations have been affected is unknown. The Times noted that the software is used in drug trials across Europe, Asia and North America. Three-quarters of trials that led to drug approvals by the U.S. Food and Drug Administration use ERT software, according to the Times.
The form of malware is unknown. ERT ticked the box of regular ransomware responses — taking its systems offline, calling in outside cybersecurity experts and contacting the U.S. Federal Bureau of Investigation.
Attacks on the healthcare system during the COVID-19 pandemic have been growing as ransomware groups attempt to leverage the serious situation to gain payments. “Healthcare is the richest target for hackers, who are never going to let the proverbial crisis go to waste,” Colin Bastable, chief executive officer of security awareness training firm Lucy Security AG, recently told SiliconANGLE. “The pandemic is going to be a big payday for many cybercriminals and state-backed bad actors.”
The most recent ransomware